69 related articles for article (PubMed ID: 30676251)
1. Evaluation of Susceptibilities to Carbapenems and Faropenem Against Cephalosporin-Resistant Neisseria gonorrhoeae Clinical Isolates with penA Mosaic Alleles.
Hiyama Y; Takahashi S; Sato T; Shinagawa M; Fukushima Y; Nakajima C; Suzuki Y; Masumori N; Yokota SI
Microb Drug Resist; 2019 Apr; 25(3):427-433. PubMed ID: 30676251
[TBL] [Abstract][Full Text] [Related]
2. Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA.
Gose S; Nguyen D; Lowenberg D; Samuel M; Bauer H; Pandori M
BMC Infect Dis; 2013 Dec; 13():570. PubMed ID: 24305088
[TBL] [Abstract][Full Text] [Related]
3. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
Lindberg R; Fredlund H; Nicholas R; Unemo M
Antimicrob Agents Chemother; 2007 Jun; 51(6):2117-22. PubMed ID: 17420216
[TBL] [Abstract][Full Text] [Related]
4. Affinity of β-Lactam Antibiotics for
Hiyama Y; Yamamoto S; Sato T; Ogasawara N; Masumori N; Takahashi S; Yokota SI
Microb Drug Resist; 2024 Mar; 30(3):141-146. PubMed ID: 38215246
[TBL] [Abstract][Full Text] [Related]
5. penA profile of Neisseria gonorrhoeae in Guangdong, China: Novel penA alleles are related to decreased susceptibility to ceftriaxone or cefixime.
Liao Y; Xie Q; Yin X; Li X; Xie J; Wu X; Tang S; Liu M; Zeng L; Pan Y; Yang J; Feng Z; Qin X; Zheng H
Int J Antimicrob Agents; 2024 Apr; 63(4):107101. PubMed ID: 38325722
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and dissemination of mosaic penicillin-binding protein 2-harboring multidrug-resistant Neisseria gonorrhoeae isolates with reduced cephalosporin susceptibility in northern Taiwan.
Huang CT; Yen MY; Wong WW; Li LH; Lin KY; Liao MH; Li SY
Antimicrob Agents Chemother; 2010 Nov; 54(11):4893-5. PubMed ID: 20733036
[TBL] [Abstract][Full Text] [Related]
7. Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study.
Grad YH; Kirkcaldy RD; Trees D; Dordel J; Harris SR; Goldstein E; Weinstock H; Parkhill J; Hanage WP; Bentley S; Lipsitch M
Lancet Infect Dis; 2014 Mar; 14(3):220-6. PubMed ID: 24462211
[TBL] [Abstract][Full Text] [Related]
8. The use of cephalosporins for gonorrhea: the impending problem of resistance.
Barry PM; Klausner JD
Expert Opin Pharmacother; 2009 Mar; 10(4):555-77. PubMed ID: 19284360
[TBL] [Abstract][Full Text] [Related]
9.
Vincent LR; Kerr SR; Tan Y; Tomberg J; Raterman EL; Dunning Hotopp JC; Unemo M; Nicholas RA; Jerse AE
mBio; 2018 Apr; 9(2):. PubMed ID: 29615507
[TBL] [Abstract][Full Text] [Related]
10. Phylogenomic analysis reveals persistence of gonococcal strains with reduced-susceptibility to extended-spectrum cephalosporins and mosaic penA-34.
Thomas JC; Joseph SJ; Cartee JC; Pham CD; Schmerer MW; Schlanger K; St Cyr SB; Kersh EN; Raphael BH;
Nat Commun; 2021 Jun; 12(1):3801. PubMed ID: 34155204
[TBL] [Abstract][Full Text] [Related]
11. RNA polymerase mutations cause cephalosporin resistance in clinical
Palace SG; Wang Y; Rubin DH; Welsh MA; Mortimer TD; Cole K; Eyre DW; Walker S; Grad YH
Elife; 2020 Feb; 9():. PubMed ID: 32011233
[TBL] [Abstract][Full Text] [Related]
12. Identification of high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates with diverse penA alleles in Zhejiang, China.
Zhang L; Hu L; Li Y; Xiu L; Wang D; Huang J; Gu W; Peng J
J Glob Antimicrob Resist; 2023 Dec; 35():51-55. PubMed ID: 37611895
[TBL] [Abstract][Full Text] [Related]
13. Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection.
Lo JY; Ho KM; Leung AO; Tiu FS; Tsang GK; Lo AC; Tapsall JW
Antimicrob Agents Chemother; 2008 Oct; 52(10):3564-7. PubMed ID: 18663018
[TBL] [Abstract][Full Text] [Related]
14. Increase in Multidrug Resistant
Zhao Y; Le W; Genco CA; Rice PA; Su X
Infect Drug Resist; 2023; 16():4053-4064. PubMed ID: 37383603
[TBL] [Abstract][Full Text] [Related]
15. Emergence and evolution of antimicrobial resistance genes and mutations in Neisseria gonorrhoeae.
Yahara K; Ma KC; Mortimer TD; Shimuta K; Nakayama SI; Hirabayashi A; Suzuki M; Jinnai M; Ohya H; Kuroki T; Watanabe Y; Yasuda M; Deguchi T; Eldholm V; Harrison OB; Maiden MCJ; Grad YH; Ohnishi M
Genome Med; 2021 Mar; 13(1):51. PubMed ID: 33785063
[TBL] [Abstract][Full Text] [Related]
16. Using the genetic characteristics of Neisseria gonorrhoeae strains with decreased susceptibility to cefixime to develop a molecular assay to predict cefixime susceptibility.
Deng X; Allan-Blitz LT; Klausner JD
Sex Health; 2019 Sep; 16(5):488-499. PubMed ID: 31230613
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic effects of ceftriaxone-resistant Neisseria gonorrhoeae FC428 mosaic-like sequences found in PenA sequences unique to Neisseria subflava and related species.
Kanesaka I; Ohno A; Morita M; Katsuse AK; Morihana T; Ito T; Takahashi H; Kobayashi I
J Antimicrob Chemother; 2023 Nov; 78(11):2683-2690. PubMed ID: 37769185
[TBL] [Abstract][Full Text] [Related]
18. Mutations in penicillin-binding protein 2 from cephalosporin-resistant
Singh A; Turner JM; Tomberg J; Fedarovich A; Unemo M; Nicholas RA; Davies C
J Biol Chem; 2020 May; 295(21):7529-7543. PubMed ID: 32253235
[TBL] [Abstract][Full Text] [Related]
19. Combined mutations of the penA with ftsX genes contribute to ceftriaxone resistance in Neisseria gonorrhoeae and peptide nucleic acids targeting these genes reverse ceftriaxone resistance.
Zhu L; Liang J; Zheng Y; Chen S; Xu Q; Yin S; Hong Y; Cao W; Lai W; Gong Z
J Glob Antimicrob Resist; 2023 Dec; 35():19-25. PubMed ID: 37567469
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the diversity and commensal origins of
Unitt A; Maiden M; Harrison O
Microb Genom; 2024 Feb; 10(2):. PubMed ID: 38381035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
